MAPT and Alzheimer disease: Furthermore, biomarker positivity does not always parallel cognitive impairment: some symptomatic individuals show normal Aβ or tau levels, whereas up to 40% of cognitively unimpaired older adults exhibit underlying AD pathology (10,11).